U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Oligoprogression

MedGen UID:
1690214
•Concept ID:
C5205436
•
Pathologic Function
Synonym: Oligoprogressive

Definition

Disease progression at a limited number of anatomic sites, in the context of stable disease at other anatomic sites. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVOligoprogression

Professional guidelines

PubMed

Treatment Landscape of Renal Cell Carcinoma.
Chen YW, Wang L, Panian J, Dhanji S, Derweesh I, Rose B, Bagrodia A, McKay RR
Curr Treat Options Oncol 2023 Dec;24(12):1889-1916. Epub 2023 Dec 28 doi: 10.1007/s11864-023-01161-5. PMID: 38153686Free PMC Article
Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.
Iyengar P, All S, Berry MF, Boike TP, Bradfield L, Dingemans AC, Feldman J, Gomez DR, Hesketh PJ, Jabbour SK, Jeter M, Josipovic M, Lievens Y, McDonald F, Perez BA, Ricardi U, Ruffini E, De Ruysscher D, Saeed H, Schneider BJ, Senan S, Widder J, Guckenberger M
Pract Radiat Oncol 2023 Sep-Oct;13(5):393-412. Epub 2023 Apr 25 doi: 10.1016/j.prro.2023.04.004. PMID: 37294262
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.
Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AC, Fournier B, Hurkmans C, Lecouvet FE, Meattini I, Méndez Romero A, Ricardi U, Russell NS, Schanne DH, Scorsetti M, Tombal B, Verellen D, Verfaillie C, Ost P
Lancet Oncol 2020 Jan;21(1):e18-e28. doi: 10.1016/S1470-2045(19)30718-1. PMID: 31908301

Recent clinical studies

Etiology

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Tsai CJ, Yang JT, Shaverdian N, Patel J, Shepherd AF, Eng J, Guttmann D, Yeh R, Gelblum DY, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie EF, Gomez DR, Lee NY, Berger M, Robson ME, Reis-Filho JS, Riaz N, Rudin CM, Powell SN; CURB Study Group
Lancet 2024 Jan 13;403(10422):171-182. Epub 2023 Dec 14 doi: 10.1016/S0140-6736(23)01857-3. PMID: 38104577Free PMC Article
Treatment Landscape of Renal Cell Carcinoma.
Chen YW, Wang L, Panian J, Dhanji S, Derweesh I, Rose B, Bagrodia A, McKay RR
Curr Treat Options Oncol 2023 Dec;24(12):1889-1916. Epub 2023 Dec 28 doi: 10.1007/s11864-023-01161-5. PMID: 38153686Free PMC Article
Optimize Local Therapy for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer to Enhance Survival.
Chang JY, Verma V
J Natl Compr Canc Netw 2022 May;20(5):531-539. doi: 10.6004/jnccn.2021.7117. PMID: 35545175
Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade.
Sindhu KK, Leiter A, Moshier E, Lin JY, Carroll E, Brooks D, Shimol JB, Eisenberg E, Gallagher EJ, Stock RG, Galsky MD, Buckstein M
Cancer Treat Res Commun 2020;25:100216. Epub 2020 Oct 8 doi: 10.1016/j.ctarc.2020.100216. PMID: 33049542
The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?
Patel PH, Palma D, McDonald F, Tree AC
Clin Oncol (R Coll Radiol) 2019 Dec;31(12):824-833. Epub 2019 Jun 8 doi: 10.1016/j.clon.2019.05.015. PMID: 31182289Free PMC Article

Diagnosis

Treatment Landscape of Renal Cell Carcinoma.
Chen YW, Wang L, Panian J, Dhanji S, Derweesh I, Rose B, Bagrodia A, McKay RR
Curr Treat Options Oncol 2023 Dec;24(12):1889-1916. Epub 2023 Dec 28 doi: 10.1007/s11864-023-01161-5. PMID: 38153686Free PMC Article
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty.
Bamias A, Stenzl A, Brown SL, Albiges L, Babjuk M, Birtle A, Briganti A, Burger M, Choudhury A, Colecchia M, De Santis M, Fanti S, Fonteyne V, Gallucci M, Rivas JG, Huddart R, Junker K, Kroeze S, Loriot Y, Merseburger A, Montironi R, Necchi A, Oing C, Oldenburg J, Ost P, Pinkawa M, Ribal MJ, Rouprêt M, Thoeny H, Zilli T, Hoskin P
Eur Urol 2023 Oct;84(4):381-389. Epub 2023 May 20 doi: 10.1016/j.eururo.2023.05.005. PMID: 37217391
Radiomics for liver tumours.
Dreher C, Linde P, Boda-Heggemann J, Baessler B
Strahlenther Onkol 2020 Oct;196(10):888-899. Epub 2020 Apr 15 doi: 10.1007/s00066-020-01615-x. PMID: 32296901Free PMC Article
Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer.
Deek MP, Tran PT
Cancer J 2020 Mar/Apr;26(2):137-143. doi: 10.1097/PPO.0000000000000432. PMID: 32205538Free PMC Article
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.
Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AC, Fournier B, Hurkmans C, Lecouvet FE, Meattini I, Méndez Romero A, Ricardi U, Russell NS, Schanne DH, Scorsetti M, Tombal B, Verellen D, Verfaillie C, Ost P
Lancet Oncol 2020 Jan;21(1):e18-e28. doi: 10.1016/S1470-2045(19)30718-1. PMID: 31908301

Therapy

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Tsai CJ, Yang JT, Shaverdian N, Patel J, Shepherd AF, Eng J, Guttmann D, Yeh R, Gelblum DY, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie EF, Gomez DR, Lee NY, Berger M, Robson ME, Reis-Filho JS, Riaz N, Rudin CM, Powell SN; CURB Study Group
Lancet 2024 Jan 13;403(10422):171-182. Epub 2023 Dec 14 doi: 10.1016/S0140-6736(23)01857-3. PMID: 38104577Free PMC Article
Role of radiation in oligometastases and oligoprogression in metastatic non-small cell lung cancer: consensus and controversy.
Kumar A, Salama JK
Expert Rev Respir Med 2023 Jul-Dec;17(11):1033-1040. Epub 2023 Dec 26 doi: 10.1080/17476348.2023.2284362. PMID: 37962878
Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.
Iyengar P, All S, Berry MF, Boike TP, Bradfield L, Dingemans AC, Feldman J, Gomez DR, Hesketh PJ, Jabbour SK, Jeter M, Josipovic M, Lievens Y, McDonald F, Perez BA, Ricardi U, Ruffini E, De Ruysscher D, Saeed H, Schneider BJ, Senan S, Widder J, Guckenberger M
Pract Radiat Oncol 2023 Sep-Oct;13(5):393-412. Epub 2023 Apr 25 doi: 10.1016/j.prro.2023.04.004. PMID: 37294262
Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer.
Deek MP, Tran PT
Cancer J 2020 Mar/Apr;26(2):137-143. doi: 10.1097/PPO.0000000000000432. PMID: 32205538Free PMC Article
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.
Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AC, Fournier B, Hurkmans C, Lecouvet FE, Meattini I, Méndez Romero A, Ricardi U, Russell NS, Schanne DH, Scorsetti M, Tombal B, Verellen D, Verfaillie C, Ost P
Lancet Oncol 2020 Jan;21(1):e18-e28. doi: 10.1016/S1470-2045(19)30718-1. PMID: 31908301

Prognosis

Treatment Landscape of Renal Cell Carcinoma.
Chen YW, Wang L, Panian J, Dhanji S, Derweesh I, Rose B, Bagrodia A, McKay RR
Curr Treat Options Oncol 2023 Dec;24(12):1889-1916. Epub 2023 Dec 28 doi: 10.1007/s11864-023-01161-5. PMID: 38153686Free PMC Article
Optimize Local Therapy for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer to Enhance Survival.
Chang JY, Verma V
J Natl Compr Canc Netw 2022 May;20(5):531-539. doi: 10.6004/jnccn.2021.7117. PMID: 35545175
Radiogenomics in Interventional Oncology.
Moussa AM, Ziv E
Curr Oncol Rep 2021 Jan 2;23(1):9. doi: 10.1007/s11912-020-00994-9. PMID: 33387095
Radiomics for liver tumours.
Dreher C, Linde P, Boda-Heggemann J, Baessler B
Strahlenther Onkol 2020 Oct;196(10):888-899. Epub 2020 Apr 15 doi: 10.1007/s00066-020-01615-x. PMID: 32296901Free PMC Article
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.
Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AC, Fournier B, Hurkmans C, Lecouvet FE, Meattini I, Méndez Romero A, Ricardi U, Russell NS, Schanne DH, Scorsetti M, Tombal B, Verellen D, Verfaillie C, Ost P
Lancet Oncol 2020 Jan;21(1):e18-e28. doi: 10.1016/S1470-2045(19)30718-1. PMID: 31908301

Clinical prediction guides

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Tsai CJ, Yang JT, Shaverdian N, Patel J, Shepherd AF, Eng J, Guttmann D, Yeh R, Gelblum DY, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie EF, Gomez DR, Lee NY, Berger M, Robson ME, Reis-Filho JS, Riaz N, Rudin CM, Powell SN; CURB Study Group
Lancet 2024 Jan 13;403(10422):171-182. Epub 2023 Dec 14 doi: 10.1016/S0140-6736(23)01857-3. PMID: 38104577Free PMC Article
Treatment Landscape of Renal Cell Carcinoma.
Chen YW, Wang L, Panian J, Dhanji S, Derweesh I, Rose B, Bagrodia A, McKay RR
Curr Treat Options Oncol 2023 Dec;24(12):1889-1916. Epub 2023 Dec 28 doi: 10.1007/s11864-023-01161-5. PMID: 38153686Free PMC Article
Radiogenomics in Interventional Oncology.
Moussa AM, Ziv E
Curr Oncol Rep 2021 Jan 2;23(1):9. doi: 10.1007/s11912-020-00994-9. PMID: 33387095
Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade.
Sindhu KK, Leiter A, Moshier E, Lin JY, Carroll E, Brooks D, Shimol JB, Eisenberg E, Gallagher EJ, Stock RG, Galsky MD, Buckstein M
Cancer Treat Res Commun 2020;25:100216. Epub 2020 Oct 8 doi: 10.1016/j.ctarc.2020.100216. PMID: 33049542
Radiomics for liver tumours.
Dreher C, Linde P, Boda-Heggemann J, Baessler B
Strahlenther Onkol 2020 Oct;196(10):888-899. Epub 2020 Apr 15 doi: 10.1007/s00066-020-01615-x. PMID: 32296901Free PMC Article

Recent systematic reviews

The Effectiveness and Safety of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Oligoprogressive Breast Cancer: A Systematic Review.
Yan B, Ramadan S, Jerzak KJ, Louie AV, Donovan E
Curr Oncol 2023 Jul 21;30(7):6976-6985. doi: 10.3390/curroncol30070505. PMID: 37504365Free PMC Article
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty.
Bamias A, Stenzl A, Brown SL, Albiges L, Babjuk M, Birtle A, Briganti A, Burger M, Choudhury A, Colecchia M, De Santis M, Fanti S, Fonteyne V, Gallucci M, Rivas JG, Huddart R, Junker K, Kroeze S, Loriot Y, Merseburger A, Montironi R, Necchi A, Oing C, Oldenburg J, Ost P, Pinkawa M, Ribal MJ, Rouprêt M, Thoeny H, Zilli T, Hoskin P
Eur Urol 2023 Oct;84(4):381-389. Epub 2023 May 20 doi: 10.1016/j.eururo.2023.05.005. PMID: 37217391
Local Therapy for Oligoprogressive Disease: A Systematic Review of Prospective Trials.
Kim H, Venkatesulu BP, McMillan MT, Verma V, Lin SH, Chang JY, Welsh JW
Int J Radiat Oncol Biol Phys 2022 Nov 15;114(4):676-683. Epub 2022 Aug 13 doi: 10.1016/j.ijrobp.2022.08.027. PMID: 35973624

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...